Comparative pathogenicity of United Kingdom isolates of the emerging pathogen Candida auris and other key pathogenic Candida species

mSphere

Volumn 1, Issue 4, 2016, Pages

  Borman, Andrew M ^a   Szekely, Adrien ^a   Johnson, Elizabeth M ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Candida auris; Emerging pathogen; Pathogenic yeasts; Pathogenicity

Indexed keywords

EID: 85027346231     PISSN: None     EISSN: 23795042     Source Type: Journal    
DOI: 10.1128/mSphere.00189-16     Document Type: Article

References (26)

1. Marr KA. 2004. Invasive Candida infections: the changing epidemiology. Oncology 18:9-14
2. Nucci M, Marr KA. 2005. Emerging fungal diseases. Clin Infect Dis 41:521-526. http://dx.doi.org/10.1086/432060
3. Pfaller MA, Jones RN, Doern GV, Fluit AC, Verhoef J, Sader HS, Messer SA, Houston A, Coffman S, Hollis RJ. 1999. International surveillance of bloodstream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). Diagn Microbiol Infect Dis 35:19-25. http://dx.doi.org/10.1016/S0732-8893(99)00046-2
4. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. 1998. National surveillance of nosocomial bloodstream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 31:327-332. http://dx.doi.org/10.1016/S0732-8893(97)00240-X
5. Ruhnke M. 2006. Epidemiology of Candida albicans infections and role of non-Candida albicans yeasts. Curr Drug Targets 7:495-504. http:// dx.doi.org/10.2174/138945006776359421
6. Snydman DR. 2003. Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 123:500S-503S. http://dx.doi.org/ 10.1378/chest.123.5_suppl.500S
7. Wingard JR. 1994. Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy. Clin Infect Dis 19(Suppl 1):S49-S53. http://dx.doi.org/10.1093/clinids/ 19.Supplement_1.S49
8. Wright WL, Wenzel RP. 1997. Nosocomial Candida. Epidemiology, transmission, and prevention. Infect Dis Clin North Am 11:411-425. http://dx.doi.org/10.1016/S0891-5520(05)70363-9
9. Moran GP, Coleman DC, Sullivan DJ. 2011. Comparative genomics and evolution of pathogenicity in human pathogenic fungi. Eukaryot Cell 10:34-42. http://dx.doi.org/10.1128/EC.00242-10
10. Borman AM, Szekely A, Linton CJ, Palmer MD, Brown P, Johnson EM. 2013. Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom. J Clin Microbiol 51: 967-972. http://dx.doi.org/10.1128/JCM.02816-12
11. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. 2009. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 53:41-44. http://dx.doi.org/10.1111/j.1348-0421.2008.00083.x
12. Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, Lee JS, Jung SI, Park KH, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW. 2009. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis 48:e57-e61. http://dx.doi.org/10.1086/597108
13. Chowdhary A, Anil Kumar V, Sharma C, Prakash A, Agarwal K, Babu R, Dinesh KR, Karim S, Singh SK, Hagen F, Meis JF. 2014. Multidrugresistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis 33:919-926. http://dx.doi.org/10.1007/s10096-013-2027-1
14. Lee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, Jang HC. 2011. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol 49:3139-3142. http://dx.doi.org/10.1128/ JCM.00319-11
15. Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, Jain S, Kathuria S, Randhawa HS, Hagen F, Meis JF. 2013. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis 19:1670-1673. http://dx.doi.org/10.3201/eid1910.130393
16. Sarma S, Kumar N, Sharma S, Govil D, Ali T, Mehta Y, Rattan A. 2013. Candidemia caused by amphotericin B and fluconazole resistant Candida auris. Indian J Med Microbiol 31:90-91. http://dx.doi.org/10.4103/ 0255-0857.108746
17. Kumar D, Banerjee T, Pratap CB, Tilak R. 2015. Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis. J Infect Dev Ctries 9:435-437
18. Magobo RE, Corcoran C, Seetharam S, Govender NP. 2014. Candida auris-associated candidemia, South Africa. Emerg Infect Dis 20: 1250-1251. http://dx.doi.org/10.3201/eid2007.131765
19. Rodero L, Cuenca-Estrella M, Córdoba S, Cahn P, Davel G, Kaufman S, Guelfand L, Rodríguez-Tudela JL. 2002. Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii. J Clin Microbiol 40:2266-2269. http://dx.doi.org/10.1128/JCM.40.6.2266-2269.2002
20. Muro MD, Motta Fde A, Burger M, Melo AS, Dalla-Costa LM. 2012. Echinocandin resistance in two Candida haemulonii isolates from pediatric patients. J Clin Microbiol 50:3783-3785. http://dx.doi.org/10.1128/ JCM.01136-12
21. Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, Meis JF, Chowdhary A. 2015. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol 53:1823-1830. http:// dx.doi.org/10.1128/JCM.00367-15
22. Girard V, Mailler S, Chetry M, Vidal C, Durand G, van Belkum A, Colombo AL, Hagen F, Meis JF, Chowdhary A. 2016. Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry. Mycoses 59: 535-538. http://dx.doi.org/10.1111/myc.12519
23. Oh BJ, Shin JH, Kim MN, Sung H, Lee K, Joo MY, Shin MG, Suh SP, Ryang DW. 2011. Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. Med Mycol 49:98-102. http://dx.doi.org/ 10.3109/13693786.2010.493563
24. Cotter G, Doyle S, Kavanagh K. 2000. Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol Med Microbiol 27:163-169. http://dx.doi.org/10.1111/j.1574-695X.2000.tb01427.x
25. Fraser M, Brown Z, Houldsworth M, Borman AM, Johnson EM. 2016. Rapid identification of 6328 isolates of pathogenic yeasts using MALDIToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database. Med Mycol 54:80-88. http://dx.doi.org/10.1093/mmy/myv085
26. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution susceptibility testing of yeasts: approved standard, 3rd ed. Document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA